Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mysoline

Known as: Draxis Brand of Primidone, Xcel Brand of Primidone, AstraZeneca Brand of Primidone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
The natural Cannabis sativa compounds, cannabidiol, cannabinol, δ9- and δ8-tetrahydrocannabinol, in that order of potency… Expand
  • figure 1
  • table 1
Review
1968
Review
1968
Epileptic disorders of unknown cause in Jerusalem, Israel, which were diagnosed during the period January, 1958, through December… Expand
Highly Cited
1964
Highly Cited
1964
Hematologic studies and microbiological assay of serum folate levels with L. casei and serum vitamin B12 concentrations with L… Expand
  • table 2
  • table 3
  • table 4
  • figure 2
1961
1961
The results of treatment of epilepsy in 282 patients hospitalized and subsequently followed in an outpatient department are… Expand
1957
1957
In the past two years, 15 cases of megaloblastic anemia occurring in patients undergoing anticonvulsant treatment with either… Expand
Highly Cited
1956
Highly Cited
1956
Summary Primidone (Mysoline) is in part converted to phenobarbital by dog and by man. Concentrations of phenobarbital found in… Expand
  • figure 1
Review
1956
Review
1956
THE first report dealing with the use of primidone (Mysoline) in the treatment of epilepsy was presented in 1952 by Handley and… Expand
1954
1954
IT IS NOW nearly a century since Sir Charles Locock' introduced the use of bromides in the treatment of epilepsy, constituting… Expand
  • table 1
1954
1954
An appreciable number of patients with seizures are not helped by the standard anticonvulsants. There is, therefore, a constant… Expand
1953
1953
The anticonvulsant properties of 5-phenyl-5-ethyl-hexahydropyrimidine-4,6-dione (Mysoline) have been compared with those of… Expand